BR100 Decreased By (-1.2%)
BR30 Decreased By (-1.31%)
KSE100 Decreased By (-0.95%)
KSE30 Decreased By (-0.95%)
AGHA 6.32 Decreased By ▼ -0.05 (-0.78%)
BECO 4.27 Decreased By ▼ -0.10 (-2.29%)
BML 62.45 Decreased By ▼ -0.19 (-0.3%)
BOP 31.23 Decreased By ▼ -0.39 (-1.23%)
CNERGY 11.59 Decreased By ▼ -0.18 (-1.53%)
CSIL 5.72 Decreased By ▼ -0.37 (-6.08%)
FCCL 61.54 Decreased By ▼ -0.55 (-0.89%)
FFL 15.02 Increased By ▲ 0.29 (1.97%)
FNEL 1.23 Increased By ▲ 0.03 (2.5%)
KEL 6.26 Increased By ▲ 0.10 (1.62%)
KOSM 5.56 Decreased By ▼ -0.12 (-2.11%)
LOTCHEM 24.68 Decreased By ▼ -0.37 (-1.48%)
MLCF 104.08 Decreased By ▼ -1.19 (-1.13%)
NBP 175.28 Decreased By ▼ -5.29 (-2.93%)
NCPL 52.77 Decreased By ▼ -0.56 (-1.05%)
NPL 54.12 Decreased By ▼ -0.67 (-1.22%)
OGDC 313.39 Decreased By ▼ -2.70 (-0.85%)
PACE 9.20 Decreased By ▼ -0.19 (-2.02%)
PAEL 35.80 Increased By ▲ 0.36 (1.02%)
PIBTL 13.47 Decreased By ▼ -0.32 (-2.32%)
PPL 221.81 Decreased By ▼ -3.54 (-1.57%)
PRL 79.08 Decreased By ▼ -1.31 (-1.63%)
PTC 46.85 Decreased By ▼ -1.17 (-2.44%)
SSGC 23.87 Decreased By ▼ -0.54 (-2.21%)
TBL 9.31 Decreased By ▼ -0.07 (-0.75%)
TELE 7.39 Decreased By ▼ -0.20 (-2.64%)
TPL 25.11 Decreased By ▼ -0.23 (-0.91%)
TPLP 12.51 Decreased By ▼ -0.59 (-4.5%)
TREET 26.25 Increased By ▲ 1.21 (4.83%)
TRG 53.44 Decreased By ▼ -1.39 (-2.54%)

A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday. Abbott Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorization to begin making the test available to healthcare providers as early as next week.
The test, which is the size of a small toaster and uses molecular technology, also shows negative results within 13 minutes, the company said in a press statement. "The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Abbott president and chief operating officer Robert Ford.
The test's small size means it can be deployed outside the "traditional four walls of a hospital in outbreak hotspots," Ford said, and Abbott is working with the FDA to send it to virus epicenters. The test has not been cleared or approved by the FDA, and has only been authorized for emergency use by approved labs and healthcare providers, the company said.

Copyright Agence France-Presse, 2020

Comments

Comments are closed for this article.